NCT03519932

Brief Summary

The objective of this study is to evaluate the subjective acceptance of comfilcon A toric contact lens, compared to samfilcon A toric lens.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
49

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 30, 2018

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

May 1, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 9, 2018

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2018

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2019

Completed
11 months until next milestone

Results Posted

Study results publicly available

January 6, 2020

Completed
Last Updated

January 6, 2020

Status Verified

December 1, 2019

Enrollment Period

6 months

First QC Date

May 1, 2018

Results QC Date

November 20, 2019

Last Update Submit

December 17, 2019

Conditions

Outcome Measures

Primary Outcomes (7)

  • Comfort at Insertion

    Subjective ratings of comfort for each pair of lenses (scale: 0-10; 0=painful,10=can't feel lens)

    Dispense

  • Comfort

    Subjective ratings of comfort for each pair of lenses (scale: 0-10; 0=painful,10=can't feel lens)

    2 weeks

  • Comfort

    Subjective ratings of comfort for each pair of lenses (scale: 0-10; 0=painful,10=can't feel lens)

    1-month

  • Lens Preference Based on Overall Comfort

    Lens preference with respect to comfort (Prefer pair-1 strongly, Prefer pair-1 slightly, Prefer pair-2 strongly, prefer pair-2 slightly, No preference)

    1 month

  • Lens Preference Based on Overall Dryness

    Lens preference with respect to dryness (Prefer pair-1 strongly, Prefer pair-1 slightly, Prefer pair-2 strongly, prefer pair-2 slightly, No preference)

    1 month

  • Dryness

    Subjective ratings of dryness for each pair of lenses (scale: 0-10; 0=Extremely dry, 10=No dryness)

    2 weeks

  • Dryness

    Subjective ratings of dryness for each pair of lenses (scale: 0-10; 0=Extremely dry, 10=No dryness)

    1-month

Secondary Outcomes (5)

  • Ease of Insertion

    Dispense

  • Ease of Insertion

    2-weeks

  • Ease of Insertion

    1-month

  • Ease of Removal

    2-weeks

  • Ease of Removal

    1 month

Study Arms (2)

comfilcon A toric lens

EXPERIMENTAL

Subjects who wear comfilcon A toric lens either as first or second pair during this cross-over study.

Device: comfilcon A toric lensDevice: samfilcon A toric lens

samfilcon A toric lens

ACTIVE COMPARATOR

Subjects who wear samfilcon A toric lens either as first or second pair during this cross-over study.

Device: comfilcon A toric lensDevice: samfilcon A toric lens

Interventions

Contact lens

Also known as: Biofinity toric, test lens
comfilcon A toric lenssamfilcon A toric lens

Contact lens

Also known as: Ultra for Astigmatism, control lens
comfilcon A toric lenssamfilcon A toric lens

Eligibility Criteria

Age17 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Is at least 17 years of age and has full legal capacity to volunteer;
  • Has had a self-reported oculo-visual examination in the last two years.
  • Has read and signed an information consent letter;
  • Is willing and able to follow instructions and maintain the appointment schedule;
  • Is an adapted soft contact lens wearer, who currently wears contact lenses for a minimum 3 days/week and 8 hours/day AND who anticipates no difficulty wearing CLs for 6 days/week, 10 hours /day.
  • Is willing to wear contact lens in both eyes for the duration of the study;
  • Has a minimum astigmatism of - 0.75, determined by refraction;
  • Can be fit with the two study contact lens types in the powers available;
  • Has a distance visual acuity of 0.20 logMAR (approx 20/30) or better, determined by refraction;
  • Can achieve a distance visual acuity of 0.20 logMAR (approx 20/30) or better in each eye with the study contact lenses.
  • Has clear corneas and no active\* ocular disease

You may not qualify if:

  • Is participating in any concurrent clinical trial;
  • Has any known active\* ocular disease and/or infection;
  • Has a systemic condition that in the opinion of the investigator may affect a study measure;
  • Is using any systemic or topical medications that in the opinion of the investigator may affect a study measure;
  • Has known sensitivity to fluorescein dye or products to be used in the study;
  • Appears to have any active\* ocular pathology, ocular anomaly or severe insufficiency of lacrimal secretion (severe dry eye) that would affect the wearing of contact lenses;
  • Is pregnant, lactating or planning a pregnancy at the time of enrolment (by verbal confirmation at the screening visit);
  • Is aphakic;
  • Has undergone refractive error surgery.
  • Has participated in the PIANO (i.e. EX-MKTG-83) Study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Waterloo

Waterloo, Ontario, N2L 3G1, Canada

Location

MeSH Terms

Conditions

Astigmatism

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Results Point of Contact

Title
Jose A.Vega OD, MSc., FAAO
Organization
CooperVision Inc.

Study Officials

  • Lyndon Jones, PhD FCOptom

    Director, Centre for Ocular Research & Education

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 1, 2018

First Posted

May 9, 2018

Study Start

April 30, 2018

Primary Completion

October 15, 2018

Study Completion

February 1, 2019

Last Updated

January 6, 2020

Results First Posted

January 6, 2020

Record last verified: 2019-12

Data Sharing

IPD Sharing
Will not share

Locations